URGN Q1 2026 Earnings Narrower Loss Surprises as Revenue Details Remain Undisclosed GNLX Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline MBWM Q1 2026 Earnings EPS Surpasses Estimates by 9 Shares Edge Lower PAM Q1 2026 Earnings Staggering EPS Beat as Operating Performance Surges OPRT Q1 2026 Earnings EPS Surpasses Estimates by 243 Despite Stock Decline